Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Biochem Cell Biol ; 41(7): 1536-46, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19166962

RESUMO

Oleic acid (OA) affects assembly of gap junctions in neonatal cardiomyocytes. Adherens junction (AJ) regulates the stability of gap junction integrity; however, the effect of OA on AJ remains largely unexplored. The distribution of N-cadherin and catenins at cell-cell junction was decreased by OA. OA induced activation of protein kinase C(PKC)-alpha and -epsilon and Src family kinase, and all three kinases were involved in the oleic acid-induced disassembly of the adherens junction, since it was blocked by pretreatment with Gö6976 (a PKCalpha inhibitor), epsilonV1-2 (a PKCepsilon inhibitor), or PP2 (a Src family kinase inhibitor). Src family kinase appeared to be the downstream of PKC-alpha and -epsilon, as blockade of either PKC-alpha or -epsilon activity prevented the OA-induced activation of Src family kinase. Immunoprecipitation analyses showed that OA activated Fyn and Fer. OA promoted the association of p120 catenin/beta-catenin with Fyn and Fer and caused increased tyrosine phosphorylation of p120 catenin and beta-catenin, resulting in decreased binding of the former to N-cadherin and of the latter to alpha-catenin. Pretreatment with PP2 abrogated this OA-induced tyrosine phosphorylation of p120 catenin and beta-catenin and restored the association of N-cadherin with p120 catenin and that of beta-catenin with alpha-catenin. In conclusion, these results show that OA activates the PKC-Fyn signaling pathway, leading to the disassembly of the AJ. Therefore, inhibitors of PKC-alpha/-epsilon and Src family kinase are potential candidates as cardioprotection agents against OA-induced heart injury during ischemia-reperfusion.


Assuntos
Junções Aderentes/efeitos dos fármacos , Junções Aderentes/enzimologia , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/enzimologia , Ácido Oleico/farmacologia , Proteína Quinase C/metabolismo , Proteínas Proto-Oncogênicas c-fyn/metabolismo , Animais , Animais Recém-Nascidos , Apoptose/efeitos dos fármacos , Cateninas , Moléculas de Adesão Celular/metabolismo , Células Cultivadas , Ativação Enzimática/efeitos dos fármacos , Modelos Biológicos , Miócitos Cardíacos/citologia , Necrose/enzimologia , Fosfoproteínas/metabolismo , Fosforilação/efeitos dos fármacos , Fosfotirosina/metabolismo , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C-alfa/metabolismo , Proteína Quinase C-épsilon/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Ratos , Ratos Wistar , beta Catenina/metabolismo , Quinases da Família src/metabolismo , delta Catenina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA